AMGN vs BGS · P/E 24, rev $10.05B vs rev $792.2M
Amgen Inc (AMGN) versus B&G Foods Inc (BGS) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
B&G Foods Inc (BGS) is a packaged foods company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported BGS revenue for 2026-07-04 was $792.2M. Net income was -$36.5M. Revenue was up 93.7% from 2026-04-04 to 2026-07-04. BGS currently screens at market cap $316.6M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. BGS currently screens at market cap $316.6M.
Not investment advice. Open the AMGN and BGS stock pages for the full models.
Not investment advice.